Is renal cryoablation becoming an effective alternative to partial nephrectomy?

Size: px
Start display at page:

Download "Is renal cryoablation becoming an effective alternative to partial nephrectomy?"

Transcription

1 Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University Hospital of Strasbourg

2

3 woman 60 y.o 8 mm RCC no CI to surgery => man 55 y.o 20 mm RCC no CI to surgery =>

4 1.Diagnostic 2.R0 resection 3.No complication 4.No recurrence

5 ANATOMOPATHOLOGY malignant benign RCC other Overall accuracy: > 90% (one biopsy) 99% (rebiopsy) type Fuhrman grading RCC subtype: identification in 93% accuracy > 90% Fuhrmann grade: accuracy variable difference = 1 grade

6

7

8

9 CT-scan

10 CT-scan

11 MRI

12 MRI

13

14 hydrodissection carbodissection

15

16 Ultrasound +/- CT ++ MRI +++

17 Ultrasound +/- CT ++ MRI +++

18

19 No histological analysis after cryo => imaging (MRI+++) COMPLICATIONS? COMPLETE ABLATION? RECURRENT DISEASE? treatment 24h 1 month 1 year death 1. lack of enhancement 2. halo sign 3. retraction of the scar M3 M6 M12

20 Percutaneous cryoablation of solitary sporadic renal cell carcinomas. Schmit et al. BJU int Technical success = 99% Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. Schmit et al. J Endourol Technical success = 97% Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy et al. AJR 2013 Technical success = 94% Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. Breen et al. BJU int Technical success = 92%

21

22

23

24

25 less complications after cryo than PN main complication: bleeding Percutaneous cryoablation of solitary sporadic renal cell carcinomas. Schmit et al. BJU int complication rate (T1a) = 4% complication rate (T1b) = 15% Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy et al. AJR 2013 complication rate = 4% more frequent for T1b Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. Breen et al. BJU int complication rate = 4,6% more frequent for T1b

26 percutaneous injection of thrombin

27 selective embolisation

28 coagulation with the cryoprobes

29 49 y.o man No CI to surgery 1,8cm RCC A. Percutaneous cryoablation is not technically feasible => PN B. Percutaneous cryoablation is feasible but more risky than surgery in this case (pyelo-ureteral junction) => PN C. Percutaneous cryoablation can be proposed to the patient as an alternative to PN => PN or cryo D. Percutaneous cryoablation = active surveillance in this case

30

31

32 134 RCC Mean size: 2,8cm 86% T1a RCC 5 years overall survival: 97,8% 5 years cancer specific survival: 100% Efficacy:

33 PN vs percutaneous ablation 1424 patients (1057 PN, 367 ablation) 3-years local recurrence free survival: - PN: 98% - Cryo: 98% - RFA: 98% Overall survival:

34 Problem: few studies with long follow-up Laparoscopic renal cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal masses: a systematic review and meta-analysis of comparative studies. Tang et al. J Laparoendosc Adv Surg Tech A Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. Klatte et al. J Urol PN > LCA laparoscopic = percutaneous?

35 Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Technique Considerations, Safety, and Local Tumor Control. Atwell et al. JVIR 2015 Technical failure = 1/46 complication rate = 15,6% 348 PN / 48 percutaneous ablation 3 years local recurrence free survival: - PN: 96% (229 patients) - Cryo: 97% (13 patients)

36 Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy et al. AJR 2013 worse outcome with T1b tumors (more recurrences and more complications) 30% of incomplete treatments and local recurrences

37 is renal cryoablation an effective alternative to partial nephrectomy? T1a Almost all tumors may be ablated with a percutaneous approach Oncological results seem almost as good as those obtained with PN BUT Few studies with large cohorts of patients and long follow-up Renal cryoablation versus robot-assisted partial nephrectomy: Washington University longterm experience. Tanagho et al. J Endourol 2013 «While RAPN offers improved DFS, for those willing to undergo close postoperative monitoring and accept the potential need for re-treatment of recurrent disease, cryoablation offers excellent long-term CSS»

38 is renal cryoablation an effective alternative to partial nephrectomy? T1b High rate of complications High rate of incomplete ablations/recurrent disease => cryoablation only for non surgical candidates

39 Team work

40

41

42

43

RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara

RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara RAPN in T1b Renal Masses? A. Mottrie G. Denaeyer, P. Schatteman, G. Novara Department of Urology O.L.V. Clinic Aalst OLV Vattikuti Robotic Surgery Institute Aalst Belgium Guidelines on Renal Cell Carcinoma

More information

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys? Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation Ronald J. Zagoria, M.D. UCSF Professor and Vice Chair Abdominal Imaging Section Chief Basics Where are your kidneys? What is ablation? Facts

More information

John Fitzpatrick Memorial Lecture. John Fitzpatrick Memorial lecture

John Fitzpatrick Memorial Lecture. John Fitzpatrick Memorial lecture John Fitzpatrick Memorial Lecture John Fitzpatrick Memorial Lecture John M Fitzpatrick, 1948 2014 Head of Research at the Irish Cancer Society Professor of Surgery and Consultant Urologist at the Mater

More information

Percutaneous ablation of renal cell carcinoma. Where do we stand now? Sanja Stojanović, Spasić Aleksandar

Percutaneous ablation of renal cell carcinoma. Where do we stand now? Sanja Stojanović, Spasić Aleksandar Percutaneous ablation of renal cell carcinoma Where do we stand now? Sanja Stojanović, Spasić Aleksandar Clinical Center of Vojvodina / Center for Radiology Novi Sad Serbia Renal cell carcinoma approximately

More information

Focal Ablative Therapies for Kidney Cancer

Focal Ablative Therapies for Kidney Cancer Focal Ablative Therapies for Kidney Cancer Robert J. Hamilton, MD, MPH, FRCSC Staff Urologist, Princess Margaret Cancer Centre Assistant Prof., Dept. of Surgery (Urology), University of Toronto ICUC January

More information

ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine

ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Sorveglianza attiva e trattamenti ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Risk of mortality in RCC patients Kutikov A. et al. J Clin Oncol 2010;

More information

What is the role of partial nephrectomy in the context of active surveillance and renal ablation?

What is the role of partial nephrectomy in the context of active surveillance and renal ablation? What is the role of partial nephrectomy in the context of active surveillance and renal ablation? Dogu Teber Department of Urology University Hospital Heidelberg Coming from Heidelberg obligates to speak

More information

Less is more: Merit of Non-Surgical Management of Kidney Cancer

Less is more: Merit of Non-Surgical Management of Kidney Cancer Less is more: Merit of Non-Surgical Management of Kidney Cancer S A T U R D A Y, A U G U S T 2 0 G H A S S A N E L - H A D D A D, MD A S S I S TA N T M E M B E R, VA S C U L A R A N D I N T E R V E N T

More information

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Indications For Partial

Indications For Partial Indications For Partial Nephrectomy Christopher G. Wood, M. D., FACS Professor and Deputy Chairman Douglas E. Johnson, M. D. Endowed Professorship in Urology Department of Urology The University of Texas

More information

Vincenzo Ficarra. Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine

Vincenzo Ficarra. Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Best Papers on Kidney Cancer Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Uro-oncological oncological topics Renal Tumor biopsy Positive Surgical Margins after

More information

Renal Mass Biopsy: Needed Now More than Ever

Renal Mass Biopsy: Needed Now More than Ever Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,

More information

Renal Mass Biopsy Should be Used for Most SRM - PRO

Renal Mass Biopsy Should be Used for Most SRM - PRO Renal Mass Biopsy Should be Used for Most SRM - PRO Tony Finelli, MD, MSc, FRCSC Head, Division of Urology GU Site Lead, Princess Margaret Cancer Center GU Cancer Lead, Cancer Care Ontario Associate Professor,

More information

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs Management options in VHL associated RCCs Challenges in RCC surgery JJ PATARD, MD, PhD Paris XI University Observation, Radical nephrectomy, Renal parenchymal sparing surgery, Open, laparoscopic, robotic

More information

Freeze, Fry or Cut. Jennifer A. Linehan, MD Associate Professor Urologic Oncology John Wayne Cancer Institute 2/9/2018

Freeze, Fry or Cut. Jennifer A. Linehan, MD Associate Professor Urologic Oncology John Wayne Cancer Institute 2/9/2018 Freeze, Fry or Cut Jennifer A. Linehan, MD Associate Professor Urologic Oncology John Wayne Cancer Institute 2/9/2018 Disclosures Consultant for UroGen Pharma. REDEFINING WHAT SURGEONS SEE Bay Area-based

More information

Contemporary Role of Renal Mass Biopsy

Contemporary Role of Renal Mass Biopsy Contemporary Role of Renal Mass Biopsy Jeffrey K. Mullins, MD Director Urologic Oncology CHI Memorial Chattanooga Urology Associates September 8, 2018 Disclosures I, Jeffrey Mullins, do not have a financial

More information

Percutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes

Percutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes Percutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes Ryan M. Hegg, Grant D. Schmit,* Stephen A. Boorjian, Robert J. McDonald, A. Nicholas Kurup,

More information

Patient Selection for Ablative Therapies. Adrian D Joyce Leeds UK

Patient Selection for Ablative Therapies. Adrian D Joyce Leeds UK Patient Selection for Ablative Adrian D Joyce Leeds UK Therapy Renal Cell Ca USA: 30,000 new cases annually >12,000 deaths RCC accounts for 3% of all adult malignancy 40% of patients will die from their

More information

RENAL CANCER. Dr. Giandomenico Roviello. Oncologia Medica Ospedale San Donato Arezzo

RENAL CANCER. Dr. Giandomenico Roviello. Oncologia Medica Ospedale San Donato Arezzo RENAL CANCER Dr. Giandomenico Roviello Oncologia Medica Ospedale San Donato Arezzo Abstracts Abstract Number: 433. Cryoablation of ct1 renal masses in the healthy patient: Early outcomes from Mayo Clinic.

More information

Vincenzo Ficarra 1,2,3. Associate Editor BJU International

Vincenzo Ficarra 1,2,3. Associate Editor BJU International Partial Nephrectomy for RCC Vincenzo Ficarra 1,2,3 1 Director Department of Urology University of Udine, Italy 2 Associate Editor BJU International 3 Scientific Director OLV Robotic Surgery Institute,

More information

Management of Locally Reccurent Renal Cell Carcinoma. Jose A. Karam, MD, FACS Assistant Professor Department of Urology

Management of Locally Reccurent Renal Cell Carcinoma. Jose A. Karam, MD, FACS Assistant Professor Department of Urology Management of Locally Reccurent Renal Cell Carcinoma Jose A. Karam, MD, FACS Assistant Professor Department of Urology DefiniAons Defini&ve treatment Aiming for cure Abla&on therapy Radiofrequency abla&on

More information

Section Activity Activity Description Details Reference(s)

Section Activity Activity Description Details Reference(s) Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with Renal Cell Carcinoma AA Cancer Centre Referrals Not routine pre-op referral indicated

More information

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE WHAT IS THE ROLE OF ACTIVE SURVEILLANCE IN THE CONTEXT OF RENAL ABLATION AND PARTIAL NEPHRECTOMY? Alessandro Volpe University of Eastern Piedmont Novara, Italy RCC INCIDENCE SEER DATABASE (1975-2006) RCC

More information

PerCryo Ablation CLINICAL DATA REVIEW 2015

PerCryo Ablation CLINICAL DATA REVIEW 2015 PerCryo Ablation CLINICAL DATA REVIEW 2015 The information contained in this booklet is being provided as a representative summary only and does not contain all available published data on cryoablation.

More information

Guidelines on Renal Cell

Guidelines on Renal Cell Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma

More information

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav Who are Candidates for Laparoscopic or Open Radical Nephrectomy Arieh Shalhav Fritz Duda Chair of Urologic Surgery Professor of Surgery and the Comprehensive Cancer Research Center Who are Candidates for

More information

How I do it: percutaneous radiofrequency ablation (RFA) Igor Sorokin, MD 1 Murthy Chamarthy, MD, 2 Jeffrey A. Cadeddu, MD 1,2 1

How I do it: percutaneous radiofrequency ablation (RFA) Igor Sorokin, MD 1 Murthy Chamarthy, MD, 2 Jeffrey A. Cadeddu, MD 1,2 1 HOW I DO IT How I do it: percutaneous radiofrequency ablation (RFA) Igor Sorokin, MD 1 Murthy Chamarthy, MD, 2 Jeffrey A. Cadeddu, MD 1,2 1 Department of Urology, UT Southwestern Medical Center, Dallas,

More information

EUROPEAN UROLOGY 61 (2012)

EUROPEAN UROLOGY 61 (2012) EUROPEAN UROLOGY 61 (2012) 1156 1161 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Alvin C. Goh and Inderbir S. Gill on pp. 1162

More information

Salvage surgery after energy ablation for renal masses

Salvage surgery after energy ablation for renal masses Salvage surgery after energy ablation for renal masses Jose A. Karam, Christopher G. Wood, Zachary R. Compton, Priya Rao*, Raghunandan Vikram, Kamran Ahrar and Surena F. Matin Departments of Urology, *Pathology,

More information

Canadian Guidelines for Management of the Small Renal Mass (SRM)

Canadian Guidelines for Management of the Small Renal Mass (SRM) Canadian Guidelines for Management of the Small Renal Mass (SRM) Michael A.S. Jewett*, Ricardo Rendon, Louis Lacombe, Pierre I. Karakiewicz, Simon Tanguay, Wes Kassouf, Mike Leveridge, Ilias Cagiannos,

More information

Presentation of Cases /Audience Voting/Panel/Discussion

Presentation of Cases /Audience Voting/Panel/Discussion Presentation of Cases /Audience Voting/Panel/Discussion JJ Patard Tim O Brien Ninth European International Kidney Cancer Symposium Dublin 25-26 April 2014 Clinical case 1 63 years old women Medical past

More information

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic renal cell carcinoma Wassim Kassouf, Leonardo L. Monteiro, Darrel E. Drachenberg, Adrian S. Fairey,

More information

Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience

Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience Washington University School of Medicine Digital Commons@Becker Open Access Publications 12-16-2013 Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience

More information

Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute

Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 23 March 2012, Sao Paulo, Brazil Surgery of RCC Locally confined (small) renal tumours Locally advanced disease Metastatic

More information

GUIDELINES ON RENAL CELL CARCINOMA

GUIDELINES ON RENAL CELL CARCINOMA GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists

More information

Hyperechoic renal masses

Hyperechoic renal masses Hyperechoic renal masses Jean-Yves Meuwly, MD Department of Diagnostic and Interventional Radiology, University Hospital Lausanne, Switzerland Department of Diagnostic and Interventional Radiology Renal

More information

Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors

Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors Grant D. Schmit,* R. Houston Thompson, Anil N. Kurup, Adam J.

More information

Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute

Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 20 April, Antalya, Turkey RCC European Union 60.000 new diagnoses/year 26.000 Cancer related deaths

More information

Complications in robotic surgery!! Review of the literature! RALP, RAPN and RARC!

Complications in robotic surgery!! Review of the literature! RALP, RAPN and RARC! Complications in robotic surgery Review of the literature RALP, RAPN and RARC Anna Wallerstedt, MD Karolinska University Hospital Stockholm, Sweden Agenda The importance of reporting surgical complications

More information

oth percutaneous radiofrequency ablation (RFA) and cryoablation have shown favorable local tumor

oth percutaneous radiofrequency ablation (RFA) and cryoablation have shown favorable local tumor Vascular and Interventional Radiology Original Research Atwell et al. Radiofrequency Ablation and Cryoablation of Small Renal Masses Vascular and Interventional Radiology Original Research Thomas D. Atwell

More information

AUA Guidelines Renal Mass and Localized Kidney Cancer

AUA Guidelines Renal Mass and Localized Kidney Cancer AUA Guidelines Renal Mass and Localized Kidney Cancer Steven C. Campbell, MD, PhD Chair AUA Guidelines Panel Professor Surgery, Vice Chair, Program Director Department of Urology Glickman Urological and

More information

Surgical Management of Renal Cancer. David Nicol Consultant Urologist

Surgical Management of Renal Cancer. David Nicol Consultant Urologist Surgical Management of Renal Cancer David Nicol Consultant Urologist Roles of Surgery 1. Curative intervention localised disease 2. Symptomatic control advanced disease 3. Augmentation of efficacy of systemic

More information

Damian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM

Damian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM Damian Dupuy, MD Image Guided Intervention (IGI) Studies 10:25 11:05 AM Image Guided Intervention (IGI) Studies Damian E. Dupuy, M.D., FACR Professor of Diagnostic Imaging The Warren Alpert Medical School

More information

Minimal invasive treatment of small renal masses

Minimal invasive treatment of small renal masses Minimal invasive treatment of small renal masses Financial disclosure: Advisor and proctor: BTG Ole Graumann, MD, PhD, Associate Professor Dep. of Radiology, Odense University Hospital Head of Radiology

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous radiofrequency ablation of renal cancer Renal cancer is cancer

More information

Complex case Presentations

Complex case Presentations Complex case Presentations Case Presentations April 2016 Lisa M Pickering Case presentations: chromophobe renal carcinoma 60 year old man. ECOG PS 0 No significant comorbodities August 2009: L radical

More information

The Incidental Renal lesion

The Incidental Renal lesion The Incidental Renal lesion BACKGROUND Increase in abdominal CT/US in last 15 years Resulted in detection of many (small) renal lesions 50% > 50yrs has at least 1 lesion majority simple cysts Renal lesions

More information

ONCOLOGIC PERCUTANEOUS INTERVENTION: 2015 UPDATE HANH VU NGHIEM, MD OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE

ONCOLOGIC PERCUTANEOUS INTERVENTION: 2015 UPDATE HANH VU NGHIEM, MD OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE ONCOLOGIC PERCUTANEOUS INTERVENTION: 2015 UPDATE HANH VU NGHIEM, MD OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE ONCOLOGIC PERCUTANEOUS IMAGE GUIDED TUMOR ABLATION Evolving, growing and increasingly

More information

Renal cryoablation of small renal masses: A Korea University experience

Renal cryoablation of small renal masses: A Korea University experience Original Article - Urological Oncology Korean J Urol 2015;56:117-124. http://dx.doi.org/10.4111/kju.2015.56.2.117 pissn 2005-6737 eissn 2005-6745 Renal cryoablation of small renal masses: A Korea University

More information

Radiofrequency ablation of kidney tumours and lesions: A review of the literature

Radiofrequency ablation of kidney tumours and lesions: A review of the literature Review Article Radiofrequency ablation of kidney tumours and lesions: A review of the literature Anthony Kodzo-Grey Venyo * Venyo AKG. Radiofrequency ablation of kidney tumours and lesions: A review of

More information

Comparison of radiographic and pathologic sizes of renal tumors

Comparison of radiographic and pathologic sizes of renal tumors ORIGINAL Article Vol. 39 (2): 189-194, March - April, 2013 doi: 10.1590/S1677-5538.IBJU.2013.02.06 Comparison of radiographic and pathologic sizes of renal tumors Wei Chen, Linhui Wang, Qing Yang, Bing

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous cryotherapy for renal cancer Treating kidney tumours by freezing

More information

Small Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas

Small Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas Small Renal Mass Guidelines Clif Vestal, MD USMD Arlington, Texas Evaluation/Diagnosis 1. Obtain high quality, multiphase, cross-sectional abdominal imaging to optimally characterize/stage the renal mass.

More information

ACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016?

ACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016? ACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016? Phillip M. Pierorazio, MD Assistant Professor of Urology and Oncology Brady Urological Institute Sidney Kimmel Cancer Center Johns Hopkins Hospital

More information

Renal biopsy is mandatory for every small renal mass

Renal biopsy is mandatory for every small renal mass Renal biopsy is mandatory for every small renal mass Ben Challacombe Consultant Urologist The Urology Centre Guy s and St. Thomas Hospital NHS Foundation Trust Oncocytoma High Risk Partial converted to

More information

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI

More information

Percutaneous cryoablation of lung tumors

Percutaneous cryoablation of lung tumors Percutaneous cryoablation of lung tumors Poster No.: C-0811 Congress: ECR 2013 Type: Authors: Keywords: DOI: Scientific Exhibit C. Pusceddu 1, L. Melis 1, G. B. Meloni 2 ; 1 Cagliari/IT, 2 Sassari/IT Lung,

More information

Mahrad Paymani, MD Lake Medical Imaging

Mahrad Paymani, MD Lake Medical Imaging Mahrad Paymani, MD Lake Medical Imaging Background: My name is Mahrad Paymani. I am an Interventional and General Radiologist. I attended four years of college (at UNC Greensboro), four years of medical

More information

were reduced by the cost of probe. With a median follow-up of 20 months there was no difference in oncological outcome.

were reduced by the cost of probe. With a median follow-up of 20 months there was no difference in oncological outcome. Laparoscopy and Robotic LAPAROSCOPIC PARTIAL NEPHRECTOMY VS LAPAROSCOPIC RADIOFREQUENCY ABLATION BENSALAH et al. Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and

More information

TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline Table of Contents Data Supplement 1: Additional Evidence Table(s) Characteristics of Studies Identified

More information

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report Case Study TheScientificWorldJOURNAL (2008) 8, 145 148 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2008.29 Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report C. Blick, N. Ravindranath,

More information

SBRT for lung metastases: Case report

SBRT for lung metastases: Case report SBRT for lung metastases: Case report Guillermo de Velasco MD, PhD University Hospital 12 de Octubre @H12O_GUCancer @g_develasco Case report 71 years old man Smoker DM 2005 Right radical nephrectomy Histology:

More information

Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions

Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions World J Urol (2015) 33:295 300 DOI 10.1007/s00345-014-1301-x ORIGINAL ARTICLE Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions Peter Weibl Milan Hora Boris Kollarik

More information

UroCryo Ablation CLINICAL DATA REVIEW HealthTronics, Inc. All rights reserved.

UroCryo Ablation CLINICAL DATA REVIEW HealthTronics, Inc. All rights reserved. UroCryo Ablation CLINICAL DATA REVIEW 2015 The information contained in this booklet is being provided as a representative summary only and does not contain all available published data on cryoablation.

More information

Use of microwave ablation in the treatment of patients with multiple primary malignant tumors

Use of microwave ablation in the treatment of patients with multiple primary malignant tumors Thoracic Cancer ISSN 1759-7706 CASE REPORT Use of microwave ablation in the treatment of patients with multiple primary malignant tumors Yue Han 1, Na Shao 2, Xiaoming Xi 3 & Xuezhi Hao 3 1 Department

More information

Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer

Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer Poster No.: C-0654 Congress: ECR 2011 Type: Scientific Paper Authors:

More information

GUIDELINES ON RENAL CELL CANCER

GUIDELINES ON RENAL CELL CANCER 20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance

More information

Questions to ask before you have a kidney removed for kidney cancer

Questions to ask before you have a kidney removed for kidney cancer Questions to ask before you have a kidney removed for kidney cancer Updated March 11, 2011 If you have a small kidney cancer (less than 7 cm.), you have several treatment options available to you. These

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Cryosurgical Ablation of Miscellaneous Solid Tumors Other Page 1 of 20 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cryosurgical Ablation of Miscellaneous Solid

More information

Prospective multi-center study of oncologic outcomes of robot-assisted partial nephrectomy for pt1 renal cell carcinoma

Prospective multi-center study of oncologic outcomes of robot-assisted partial nephrectomy for pt1 renal cell carcinoma Washington University School of Medicine Digital Commons@Becker Open Access Publications 2012 Prospective multi-center study of oncologic outcomes of robot-assisted partial nephrectomy for pt1 renal cell

More information

Directness Consistency Precision Reporting Bias

Directness Consistency Precision Reporting Bias responsible for the accuracy and presentation of the material. Supplemental Table. Strength of evidence for primary. Key Outcomes* Studies (N) Study limitations Directness Consistency Precision Reporting

More information

Renal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others

Renal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of

More information

Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Advances in Urology Volume 2016, Article ID 8045210, 6 pages http://dx.doi.org/10.1155/2016/8045210 Clinical Study Radiofrequency Ablation-Assisted Zero-Ischemia Robotic Laparoscopic Partial Nephrectomy:

More information

Prostate, or Dermatologic Tumors. Description

Prostate, or Dermatologic Tumors. Description Last Review Status/Date: September 2015 Page: 1 of 15 Description Cryosurgical ablation (hereafter referred to as cryosurgery or cryoablation) involves freezing of target tissues, most often by inserting

More information

James Cassuto, MS IV. Shekher Maddineni, MD Samuel McCabe, MD Vascular and Interventional Radiology

James Cassuto, MS IV. Shekher Maddineni, MD Samuel McCabe, MD Vascular and Interventional Radiology Student: Attendings: Department: James Cassuto, MS IV Grigory Rozenblit, MD Shekher Maddineni, MD Samuel McCabe, MD Vascular and Interventional Radiology Chief Complaint & HPI 61 year old female who is

More information

PerCryo Ablation CLINICAL DATA REVIEW 2016

PerCryo Ablation CLINICAL DATA REVIEW 2016 PerCryo Ablation CLINICAL DATA REVIEW 2016 The information contained in this booklet is being provided as a representative summary only and does not contain all available published data on cryoablation.

More information

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5)

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) Universally recognized post-nephrectomy cancer treatment. Sampling: National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology

More information

St. Dominic s Annual Cancer Report Outcomes

St. Dominic s Annual Cancer Report Outcomes St. Dominic s 2017 Annual Cancer Report Outcomes Cancer Program Practice Profile Reports (CP3R) St. Dominic s Cancer Committee monitors and ensures that patients treated at St. Dominic Hospital receive

More information

Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors

Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors 7.01.92 Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors Section 7.0 Surgery Subsection Description Effective Date January 1, 2015 Original Policy

More information

Over 35,000 new cases of renal

Over 35,000 new cases of renal DEBRA A. GERVAIS, MD Director of Abdominal Interventional Radiology Assistant Professor of Radiology RONALD S. ARELLANO, MD Director of Abdominal Intervention Clinic Operations Instructor of Radiology

More information

Robotic-assisted ipsilateral adrenalectomy after robotic-assisted partial nephrectomy: a case report

Robotic-assisted ipsilateral adrenalectomy after robotic-assisted partial nephrectomy: a case report Case Report Page 1 of 5 Robotic-assisted ipsilateral adrenalectomy after robotic-assisted partial nephrectomy: a case report David P. Feng 1, Zuliang Feng 2, Amy N. Luckenbaugh 1, Svetlana Avulova 1, Daniel

More information

Clinical Study The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation

Clinical Study The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation Advances in Urology Volume 2012, Article ID 539648, 6 pages doi:10.1155/2012/539648 Clinical Study The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation B. W. Lagerveld, 1 H. van Dekken,

More information

Lymphadenectomy in RCC: Yes, No, Clinical Trial?

Lymphadenectomy in RCC: Yes, No, Clinical Trial? Lymphadenectomy in RCC: Yes, No, Clinical Trial? Viraj Master MD PhD FACS Professor Associate Chair for Clinical Affairs and Quality Director of Clinical Research Unit Department of Urology Emory University

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Florida Cancer Specialist & Research Institute, Sebastian and Vero Beach, Fl, USA 3

Florida Cancer Specialist & Research Institute, Sebastian and Vero Beach, Fl, USA 3 Evaluation of Perioperative Outcomes and Renal Function after Robotic Assisted Laparoscopic Partial Nephrectomy Off/On Clamp: Comparison of ct1a versus ct1b Renal Masses Hugo H Davila 1-4*, Raul E Storey

More information

ROBOTIC VS OPEN RADICAL CYSTECTOMY

ROBOTIC VS OPEN RADICAL CYSTECTOMY ROBOTIC VS OPEN RADICAL CYSTECTOMY A REVIEW Colin Lundeen December 14, 2016 Objectives Review the history of radical cystectomy Critically analyze recent RCTs comparing open radical cystectomy (ORC) to

More information

The Incidental Renal Mass in the Primary Care Setting

The Incidental Renal Mass in the Primary Care Setting The Incidental Renal Mass in the Primary Care Setting Adele M. Caruso, MSN, CRNP Adult Nurse Practitioner The Perelman School of Medicine at the University of Pennsylvania Abstract There are approximately

More information

Clinical/Surgical trials that will change my practice

Clinical/Surgical trials that will change my practice Clinical/Surgical trials that will change my practice Mr Jim M Adshead Herts and Beds Urological Cancer Centre, Lister Hospital What s changed and where do I feel we are clutching at straws? Regional Specialist

More information

BJUI. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy

BJUI. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy BJUI Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy Nilay Patel, David Cranston, M. Zeeshan Akhtar, Caroline George, Andrew

More information

MEDICAL POLICY SUBJECT: CRYOSURGICAL TUMOR ABLATION. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: CRYOSURGICAL TUMOR ABLATION. POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: CRYOSURGICAL TUMOR PAGE: 1 OF:13 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including an

More information

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it

More information

Indications for biopsy and the current status of focal therapy for renal tumours

Indications for biopsy and the current status of focal therapy for renal tumours Review Article Indications for biopsy and the current status of focal therapy for renal tumours Ricardo R.N. Leão, Patrick O. Richard, Michael A.S. Jewett Department of Surgery (Urology) and Surgical Oncology,

More information

The Surgical Management of RCC

The Surgical Management of RCC The Surgical Management of RCC From Robson to Radiofrequency Ablation Tony Finelli, MD, MSc, FRCSC University Health Network University of Toronto Background Renal cell carcinoma (RCC) is 9 th most common

More information

Appendix 4 Urology Care Pathways

Appendix 4 Urology Care Pathways Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable

More information

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management Nicholas G. Cost, M.D. Assistant Professor, Department of Surgery, Division of Urology University of Colorado Cancer Center Fifteenth

More information

Oncourology COMPLICATIONS OF PARTIAL NEPHRECTOMY AT OPERATIVE TREATMENT OF RENAL CELL CARCINOMA

Oncourology COMPLICATIONS OF PARTIAL NEPHRECTOMY AT OPERATIVE TREATMENT OF RENAL CELL CARCINOMA 1 Oncourology COMPLICATIONS OF PARTIAL NEPHRECTOMY AT OPERATIVE TREATMENT OF RENAL CELL CARCINOMA Address: Eduard Oleksandrovych Stakhovsky, 03022, Kyiv, Lomonosova Str., 33/43, National Cancer Institute

More information

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D. Patient Selection for Surgery in RCC with Thrombus E. Jason Abel, M.D. RCC with venous invasion Venous invasion occurs in ~10% of RCC Surgery more complex Increased risk for morbidity Thrombus may be confined

More information

3.1 Investigations for Patients Presenting with Haematuria Table 1

3.1 Investigations for Patients Presenting with Haematuria Table 1 3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements

More information

Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.

Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D. Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.. Eighth European International Kidney Cancer Symposium Budapest 03-04 May 2013 The role of LND In organ confined

More information

Patient and nonradiographic tumor characteristics predicting lipid-poor angiomyolipoma in small renal masses: Introducing the BEARS index

Patient and nonradiographic tumor characteristics predicting lipid-poor angiomyolipoma in small renal masses: Introducing the BEARS index Washington University School of Medicine Digital Commons@Becker Open Access Publications 2017 Patient and nonradiographic tumor characteristics predicting lipid-poor angiomyolipoma in small renal masses:

More information